featured news
- Science Commons' John Wilbanks Interviewed
- John Wilbanks, co-founder of Health Commons, was interviewed by O'Reilly in conjunction with the upcoming eTech 2009 conference.
Read more » - CollabRx's Marty Tenenbaum profiled in the Wall Street Journal
- Marty Tenenbaum, co-founder of Health Commons, was profiled by the Wall Street Journal about empowering users in drug discovery.
Read more ยป
upcoming events
25.02.09 - Marty Tenenbaum delivers CHI Medicine Tri-Conference Plenary Keynote
Using Molecular Medicine to do Therapeutic Development in the Network Age
Jay M. Tenenbaum, Ph.D., Chairman and Chief Scientist, CollabRx, Inc
A new paradigm for translational research will be described that combines the integrative and collaborative power of the Internet with personalized molecular analysis to slash the time and cost of therapy development. The creation of Health Commons involves an open web-based ecosystem of researchers, clinicians, patients, pharma/biotechs, and service/technology providers that can be rapidly mobilized to develop targeted therapies for disease subclasses. This ecosystem will stimulate the same radical increase in efficiency for therapy development that ecommerce brought to business in the 1990s, ushering in a new age of collaborative, personalized medicine where every patient can afford custom therapies and discovery is driven by collectively interpreting the outcomes across all patients.
11.03.09 - John Wilbanks at O'Reilly eTech 2009
John Wilbanks speaks at the O'Reilly emerging technologies conference on the relationship between access and innovation in the sciences.
Except where otherwise noted, this work is
licensed under a Creative Commons Attribution 3.0 License.